These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 7501734)

  • 1. Cognitive and psychophysiological correlates of positive, negative, and disorganized symptoms in the schizophrenia spectrum.
    Brekke JS; Raine A; Thomson C
    Psychiatry Res; 1995 Aug; 57(3):241-50. PubMed ID: 7501734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive disorders in the positive, negative, and disorganization syndromes of schizophrenia.
    Cuesta MJ; Peralta V
    Psychiatry Res; 1995 Oct; 58(3):227-35. PubMed ID: 8570778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropsychological and psychophysiological correlates of psychosocial functioning in schizophrenia.
    Brekke JS; Raine A; Ansel M; Lencz T; Bird L
    Schizophr Bull; 1997; 23(1):19-28. PubMed ID: 9050110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the ability to sustain attention underlie symptom severity in schizophrenia?
    O'Gráda C; Barry S; McGlade N; Behan C; Haq F; Hayden J; O'Donoghue T; Peel R; Morris DW; O'Callaghan E; Gill M; Corvin AP; Dinan TG; Donohoe G
    Schizophr Res; 2009 Feb; 107(2-3):319-23. PubMed ID: 18768299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive inhibition and schizophrenic symptom subgroups.
    Williams LM
    Schizophr Bull; 1996; 22(1):139-51. PubMed ID: 8685656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Organization and representation of action in schizophrenia].
    Georgieff N
    Encephale; 1996 Oct; 22 Spec No 3():108-15. PubMed ID: 9036002
    [No Abstract]   [Full Text] [Related]  

  • 7. The complex relationships between executive functions and positive symptoms in schizophrenia.
    Guillem F; Rinaldi M; Pampoulova T; Stip E
    Psychol Med; 2008 Jun; 38(6):853-60. PubMed ID: 18261245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Internal consistency, temporal stability and neuropsychological correlates of three cognitive components of the Positive and Negative Syndrome Scale (PANSS).
    Bryson G; Bell M; Greig T; Kaplan E
    Schizophr Res; 1999 Jul; 38(1):27-35. PubMed ID: 10427608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive correlates of the negative, disorganized, and psychotic symptom dimensions of schizophrenia.
    O'Leary DS; Flaum M; Kesler ML; Flashman LA; Arndt S; Andreasen NC
    J Neuropsychiatry Clin Neurosci; 2000; 12(1):4-15. PubMed ID: 10678506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theory of mind performance in schizophrenia: diagnostic, symptom, and neuropsychological correlates.
    Greig TC; Bryson GJ; Bell MD
    J Nerv Ment Dis; 2004 Jan; 192(1):12-8. PubMed ID: 14718771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risperidone, negative symptoms and cognitive deficit in schizophrenia: an open study.
    Rossi A; Mancini F; Stratta P; Mattei P; Gismondi R; Pozzi F; Casacchia M
    Acta Psychiatr Scand; 1997 Jan; 95(1):40-3. PubMed ID: 9051159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disorganization and cognitive impairment in schizophrenia: independent symptom dimensions?
    Klingberg S; Wittorf A; Wiedemann G
    Eur Arch Psychiatry Clin Neurosci; 2006 Dec; 256(8):532-40. PubMed ID: 17164977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automatic affective processing impairments in patients with deficit syndrome schizophrenia.
    Strauss GP; Allen DN; Duke LA; Ross SA; Schwartz J
    Schizophr Res; 2008 Jul; 102(1-3):76-87. PubMed ID: 18313270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Affective reactivity of cognitive functioning and family history in schizophrenia.
    Docherty NM; Grosh ES; Wexler BE
    Biol Psychiatry; 1996 Jan; 39(1):59-64. PubMed ID: 8719127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symptom segregation in chronic schizophrenia: the significance of thought disorder.
    Sarai M; Matsunaga H
    Schizophr Res; 1993 Aug; 10(2):159-63. PubMed ID: 8398948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three syndrome concept of schizophrenia. A factor analytic study.
    Malla AK; Norman RM; Williamson P; Cortese L; Diaz F
    Schizophr Res; 1993 Aug; 10(2):143-50. PubMed ID: 8398946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up.
    Milev P; Ho BC; Arndt S; Andreasen NC
    Am J Psychiatry; 2005 Mar; 162(3):495-506. PubMed ID: 15741466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurocognitive deficits or stress overload: Why do individuals with schizophrenia show poor performance in neurocognitive tests?
    Krkovic K; Moritz S; Lincoln TM
    Schizophr Res; 2017 May; 183():151-156. PubMed ID: 27838097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical attributes of schizophrenic skin conductance responders and non-responders.
    Gruzelier JH
    Psychol Med; 1976 May; 6(2):245-9. PubMed ID: 826921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Theory of mind in schizophrenia: the role of clinical symptomatology and neurocognition in understanding other people's thoughts and intentions.
    Abdel-Hamid M; Lehmkämper C; Sonntag C; Juckel G; Daum I; Brüne M
    Psychiatry Res; 2009 Jan; 165(1-2):19-26. PubMed ID: 19073346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.